Combining lapatinib (GW572016), a small molecule inhibitor of ErbB1 and ErbB2 tyrosine kinases, with therapeutic anti-ErbB2 antibodies enhances apoptosis of ErbB2-overexpressing breast cancer cells
(Q27824846)
scientific article
scientific article
Language:
other details
description | scientific article |
External Links
(P356) |
10.1038/SJ.ONC.1208774
|
(P698) |
16091755
|
(P3181) |
4704418
|
(P5875) |
7668131
|
(P6179) |
1031051961
|